Regenerative Medicine News

    Hyperspectral Imaging: Shedding New Light on Wound Healing     Clinicians who treat severe wounds may soon have powerful new diagnostic tools in the form of hyperspectral imaging (HSI) devices, calibrated to new NIST standard reference spec ...[Read More]

  Stem Cell Therapy for Peripheral Artery Disease 9/10 A new treatment option, using a person’s own stem cells, could hold promise for some of the hundreds of thousands of patients suffering from critical limb ischemia, which blocks blood flow to ...[Read More]

  Ohio State Receives $1.4 Million for Burn Wound Care Research COLUMBUS, Ohio – Scientists from The Ohio State University College of Medicine were recently awarded funding from the United States Department of Defense for wound treatment research ...[Read More]

  SickKids First to Grow Lung Cells Using Stem Cell Technology August 26, 2012 - (SickKids) -"New stem cell research paves the way towards individualized medicine for patients with cystic fibrosis and other lung diseases. The study, led by Th ...[Read More]

  Stem Cell-Powered Implant Set to Revolutionise Orthopaedic Surgery August 30, 2012 - (University of Glasgow) - "Scientists at the University of Glasgow are working to harness the regenerative power of stem cells to improve orthopaedic imp ...[Read More]

  Alcohol By-Product Destroys Blood Stem Cells August 26, 2012 - (Medical Research Council) - "Scientists at the Medical Research Council (MRC) Laboratory of Molecular Biology have found that stem cells in the body’s ‘blood cell factory’ – th ...[Read More]

  Stem Cell Action Coalition Applauds Federal Circuit Court Decision in the Sherley v. Sebelius Case August 24, 2012 - (GPI) - "The following statement may be attributed to Bernard Siegel, J.D., spokesperson for the Stem Cell Action Coalition ...[Read More]

  Pluristem Files for Orphan Drug Status with U.S. FDA for Use of PLX Cells in Treatment of Aplastic Anemia August 30, 2012 - (Pluristem) -"Pluristem Therapeutics, Inc. a leading developer of placenta-based cell therapies, today announced tha ...[Read More]

  Neuralstem Completes Phase I ALS Stem Cell Trial August 27, 2012 - (Neuralstem) - "Neuralstem, Inc. announced the completion of the Phase I trial of its NSI-566 spinal cord neural stem cells for the treatment of amyotrophic lateral sclerosi ...[Read More]

  StemCells, Inc. Reports Positive Interim Data From Spinal Cord Injury Trial September 3, 2012 - (StemCells, Inc.) - "StemCells, Inc. today announced that interim six-month data from the first patient cohort in the Company's Phase I/II clini ...[Read More]